IDEAS home Printed from https://ideas.repec.org/r/nbr/nberwo/8818.html
   My bibliography  Save this item

The Health of Nations: The Contribution of Improved Health to Living Standards

Citations

Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
as


Cited by:

  1. Badi H. Baltagi & Raffaele Lagravinese & Francesco Moscone & Elisa Tosetti, 2017. "Health Care Expenditure and Income: A Global Perspective," Health Economics, John Wiley & Sons, Ltd., vol. 26(7), pages 863-874, July.
  2. David Cutler & Angus Deaton & Adriana Lleras-Muney, 2006. "The Determinants of Mortality," Journal of Economic Perspectives, American Economic Association, vol. 20(3), pages 97-120, Summer.
  3. Frank R. Lichtenberg & Suchin Virabhak, 2007. "Pharmaceutical-embodied technical progress, longevity, and quality of life: drugs as 'Equipment for Your Health'," Managerial and Decision Economics, John Wiley & Sons, Ltd., vol. 28(4-5), pages 371-392.
  4. Lars Osberg & Andrew Sharpe, 2003. "Human Well-being and Economic Well-being: What Values Are Implicit in Current Indices?," CSLS Research Reports 2003-04, Centre for the Study of Living Standards.
  5. Cormac Ó Gráda, 2005. "You Take the High Road and I’ll Take the Low Road - Economic Success and Wellbeing in the Longer Run," Working Papers 200510, School of Economics, University College Dublin.
  6. Boris Begović, 2016. "The Rise and Fall of American Growth: The U.S. Standard of Living since the Civil War by Robert J. Gordon," Panoeconomicus, Savez ekonomista Vojvodine, Novi Sad, Serbia, vol. 63(5), pages 627-636, December.
  7. Namkee Ahn, "undated". "Assessing Self-Assessed Health Data," Working Papers 2002-24, FEDEA.
  8. Seema Jayachandran & Adriana Lleras-Muney & Kimberly V. Smith, 2009. "Modern Medicine and the 20th Century Decline in Mortality: Evidence on the Impact of Sulfa Drugs," NBER Working Papers 15089, National Bureau of Economic Research, Inc.
  9. The Untold Standards of Living Story: The GDP value of Twentieth Century Health Improvements in Developed Economies, 2012. "Hickson, Kerry," CAGE Online Working Paper Series 105, Competitive Advantage in the Global Economy (CAGE).
  10. Arrow, Kenneth J. & Dasgupta, Partha & Goulder, Lawrence H. & Mumford, Kevin J. & Oleson, Kirsten, 2012. "Sustainability and the measurement of wealth," Environment and Development Economics, Cambridge University Press, vol. 17(3), pages 317-353, June.
  11. Saleema Razvi & Amir Ullah Khan, 2015. "Health Financing in South Asia—The Role of Public–Private Partnerships," South Asian Survey, , vol. 22(1), pages 15-36, March.
  12. Joseph J. Doyle, Jr., 2007. "Returns to Local-Area Health Care Spending: Using Health Shocks to Patients Far From Home," NBER Working Papers 13301, National Bureau of Economic Research, Inc.
  13. Vrachimis Konstantinos & Zachariadis Marios, 2013. "A contribution to the empirics of welfare growth," The B.E. Journal of Macroeconomics, De Gruyter, vol. 13(1), pages 1-32, April.
  14. Ruiz-Tagle, Jaime & Tapia, Pablo, 2011. "Chile: early retirement, impatience and risk aversion," Revista CEPAL, Naciones Unidas Comisión Económica para América Latina y el Caribe (CEPAL), December.
  15. Douglas Almond & Joseph J. Doyle & Amanda E. Kowalski & Heidi Williams, 2010. "Estimating Marginal Returns to Medical Care: Evidence from At-risk Newborns," The Quarterly Journal of Economics, President and Fellows of Harvard College, vol. 125(2), pages 591-634.
  16. Peter Juul Egedesø & Casper Worm Hansen & Peter Sandholt Jensen, 2020. "Preventing the White Death: Tuberculosis Dispensaries," The Economic Journal, Royal Economic Society, vol. 130(629), pages 1288-1316.
  17. Lee Branstetter & Chirantan Chatterjee & Matthew J. Higgins, 2016. "Regulation and welfare: evidence from paragraph IV generic entry in the pharmaceutical industry," RAND Journal of Economics, RAND Corporation, vol. 47(4), pages 857-890, November.
  18. Colombier, Carsten, 2012. "Drivers of health care expenditure: Does Baumol's cost disease loom large?," FiFo Discussion Papers - Finanzwissenschaftliche Diskussionsbeiträge 12-5, University of Cologne, FiFo Institute for Public Economics.
  19. Kerry Hickson, 2014. "The GDP Value of Twentieth-Century Health Improvements in Developed Economies: Initial Estimates for England," Review of Income and Wealth, International Association for Research in Income and Wealth, vol. 60(2), pages 385-399, June.
  20. Frank Lichtenberg, 2010. "The Contribution of Pharmaceutical Innovation to Longevity Growth in Germany and France," CESifo Working Paper Series 3095, CESifo.
  21. Cormac Ó Gráda, 2005. "The tortoise and the hare : economic growth in Britain and the Netherlands c.1500-1800," Working Papers 200524, School of Economics, University College Dublin.
  22. Fabio Pammolli & Massimo Riccaboni & Nicola Carmine Salerno, 2012. "I Farmaci Oncologici in Italia: innovazione e sostenibilità economica," Working Papers CERM 02-2012, Competitività, Regole, Mercati (CERM).
  23. Francisco José Goerlich Gisbert & Rafael Pinilla Pallejà, 2003. "Distribución De La Renta Y El Potencial De Calidad De Vida (Qlp) En España (1981-1999)," Working Papers. Serie EC 2003-03, Instituto Valenciano de Investigaciones Económicas, S.A. (Ivie).
  24. Bhaven N. Sampat, 2015. "Intellectual property rights and pharmaceuticals: The case of antibiotics," WIPO Economic Research Working Papers 26, World Intellectual Property Organization - Economics and Statistics Division.
  25. Robert J. Gordon, 2006. "The Boskin Commission Report: A Retrospective One Decade Later," International Productivity Monitor, Centre for the Study of Living Standards, vol. 12, pages 7-22, Spring.
  26. S. Grosskopf & S. Self & O. Zaim, 2006. "Estimating the efficiency of the system of healthcare financing in achieving better health," Applied Economics, Taylor & Francis Journals, vol. 38(13), pages 1477-1488.
  27. Junying Zhao & William Scarth & Jeremiah Hurley, 2018. "Investing in Health: A Macroeconomic Exploration of Short-Run and Long-Run Trade-Offs," Atlantic Economic Journal, Springer;International Atlantic Economic Society, vol. 46(1), pages 121-133, March.
  28. Mohajan, Haradhan, 2011. "Air pollution causes health effects and net national product of a country decreases: a theoretical framework," MPRA Paper 50858, University Library of Munich, Germany, revised 23 May 2012.
  29. Nicholas Crafts, 2016. "The Rise and Fall of American Growth: Exploring the Numbers," American Economic Review, American Economic Association, vol. 106(5), pages 57-60, May.
  30. Lamontagne, Erik & Over, Mead & Stover, John, 2019. "The economic returns of ending the AIDS epidemic as a public health threat," Health Policy, Elsevier, vol. 123(1), pages 104-108.
  31. Mohajan, Haradhan, 2011. "Valuing health impacts of the workers in Bangladesh due to air pollution," MPRA Paper 50697, University Library of Munich, Germany, revised 13 May 2011.
  32. Ács, Pongrác & Hécz, Roland & Paár, Dávid & Stocker, Miklós, 2011. "A fittség (m)értéke. A fizikai inaktivitás nemzetgazdasági terhei Magyarországon [The value (degree) of fitness. The national economic costs of physical inactivity in Hungary]," Közgazdasági Szemle (Economic Review - monthly of the Hungarian Academy of Sciences), Közgazdasági Szemle Alapítvány (Economic Review Foundation), vol. 0(7), pages 689-708.
  33. Francesco Ricci & Marios Zachariadis, 2006. "Determinants of Public Health Outcomes: A Macroeconomic Perspective," DEGIT Conference Papers c011_045, DEGIT, Dynamics, Economic Growth, and International Trade.
  34. Di Tella, Rafael & MacCulloch, Robert, 2008. "Gross national happiness as an answer to the Easterlin Paradox?," Journal of Development Economics, Elsevier, vol. 86(1), pages 22-42, April.
  35. Sherry Glied, 2003. "Health Care Costs: On the Rise Again," Journal of Economic Perspectives, American Economic Association, vol. 17(2), pages 125-148, Spring.
  36. Gordon Anderson & Oliver Linton & Teng Leo, 2012. "A polarization-cohesion perspective on cross-country convergence," Journal of Economic Growth, Springer, vol. 17(1), pages 49-69, March.
  37. Frank Lichtenberg, 2011. "The quality of medical care, behavioral risk factors, and longevity growth," International Journal of Health Economics and Management, Springer, vol. 11(1), pages 1-34, March.
  38. Frank Lichtenberg, 2005. "The Impact of New Drug Launches on Longevity: Evidence from Longitudinal, Disease-Level Data from 52 Countries, 1982–2001," International Journal of Health Economics and Management, Springer, vol. 5(1), pages 47-73, January.
  39. Rafael di Tella & Ernesto Schargrodsky, 2009. "Happiness, Ideology and Crime in Argentine Cities," Research Department Publications 4645, Inter-American Development Bank, Research Department.
  40. Stolpe, Michael, 2003. "Ressourcen und Ergebnisse der globalen Gesundheitsökonomie: Einführung und Überblick," Kiel Working Papers 1177, Kiel Institute for the World Economy (IfW Kiel).
  41. Junying Zhao & William Scarth & Jeremiah Hurley, 2015. "Investing in Health: A Macroeconomic Exploration of Short-Run and Long-Run Trade-Offs," Department of Economics Working Papers 2015-15, McMaster University.
  42. Md. Mohsin Reza & Thirunaukarasu Subramaniam & M. Rezaul Islam, 2019. "Economic and Social Well-Being of Asian Labour Migrants: A Literature Review," Social Indicators Research: An International and Interdisciplinary Journal for Quality-of-Life Measurement, Springer, vol. 141(3), pages 1245-1264, February.
  43. Anni Huhtala & Eva Samakovlis, 2007. "Flows of Air Pollution, Ill Health and Welfare," Environmental & Resource Economics, Springer;European Association of Environmental and Resource Economists, vol. 37(2), pages 445-463, June.
  44. Fimpel, Julia & Stolpe, Michael, 2006. "The welfare costs of HIV/AIDS in Eastern Europe: An empirical assessment using the economic value-of-life approach," Kiel Working Papers 1297, Kiel Institute for the World Economy (IfW Kiel).
  45. Oliviero Carboni & Paolo Russu, 2015. "Assessing Regional Wellbeing in Italy: An Application of Malmquist–DEA and Self-organizing Map Neural Clustering," Social Indicators Research: An International and Interdisciplinary Journal for Quality-of-Life Measurement, Springer, vol. 122(3), pages 677-700, July.
  46. Egan, Mark L. & Mulligan, Casey B. & Philipson, Tomas J., 2013. "Adjusting Measures of Economic Output for Health: Is the Business Cycle Countercyclical?," Working Papers 246, The University of Chicago Booth School of Business, George J. Stigler Center for the Study of the Economy and the State.
  47. Goerlich, Francisco José & Pinilla, Rafael, 2005. "Esperanza de Vida y Potencial de Vida a lo largo del siglo XX en España [Live Expectancy and Potential throughout the twentieth century in Spain]," MPRA Paper 15911, University Library of Munich, Germany, revised 2005.
  48. Richard Heijink & Xander Koolman & Gert Westert, 2013. "Spending more money, saving more lives? The relationship between avoidable mortality and healthcare spending in 14 countries," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 14(3), pages 527-538, June.
  49. Charles I. Jones, 2001. "The economic return to health expenditures," FRBSF Economic Letter, Federal Reserve Bank of San Francisco, issue dec14.
IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.